Amplify Weight Loss Drug & Treatment ETF Rating $24.76 +0.08 (+0.32%) As of 05/5/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Amplify Weight Loss Drug & Treatment ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.THNR Aggregate RatingModerate Buy 2.60Holdings in THNR have an aggregate rating of Moderate Buy based on 239 analyst ratings issued in the past year covering 11 companies (64.4% of the portfolio).THNR Aggregate Price Target$24.76High Prediction$24.76Average Prediction$24.76Low Prediction$24.76Holdings in THNR have an aggregate price target of $24.76 and a range of $24.76 to $24.76 covering 11 companies (64.4% of the portfolio).THNR Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy7 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Amplify Weight Loss Drug & Treatment ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 11 THNR Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings13.85%NVONovo Nordisk A/S$44.87+1.1%4.7742 of 5 stars2.13$65.56 46.1%23Trending NewsUpcoming Earnings11.91%LLYEli Lilly and Company$989.02+2.2%4.877 of 5 stars2.87$1,217.59 23.1%30Trending NewsEarnings ReportDividend AnnouncementAnalyst Upgrade6.29%REGNRegeneron Pharmaceuticals$702.45-1.0%4.4201 of 5 stars2.77$826.59 17.7%26Earnings ReportDividend Announcement6.25%AMGNAmgen$329.59+1.8%4.5779 of 5 stars2.42$357.12 8.4%31Trending NewsEarnings ReportAnalyst ForecastInsider Trade5.82%ARWRArrowhead Pharmaceuticals$74.93-1.9%2.6245 of 5 stars2.83$84.20 12.4%12News CoverageUpcoming Earnings4.89%PFEPfizer$26.42+0.5%3.9539 of 5 stars2.23$28.74 8.8%22Trending NewsEarnings Report4.64%MRKMerck & Co., Inc.$113.21+0.1%4.8114 of 5 stars2.68$128.18 13.2%19Trending NewsEarnings Report4.62%ABBVAbbVie$206.12-1.0%4.9091 of 5 stars2.85$252.90 22.7%26Trending NewsEarnings Report2.25%SRRKScholar Rock$47.13+1.4%3.4273 of 5 stars3.17$55.40 17.5%18Upcoming Earnings2.12%VKTXViking Therapeutics$31.31-1.4%3.6313 of 5 stars2.85$95.50 205.0%13News CoverageEarnings ReportAnalyst Revision1.74%GPCRStructure Therapeutics$41.10-4.5%2.7628 of 5 stars2.89$109.25 165.8%19Upcoming Earnings This page (NYSEARCA:THNR) was last updated on 5/6/2026 by MarketBeat.com Staff. From Our PartnersYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredI’m sounding the alarmMeta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...Porter & Company | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHow to collect $1,170/month from silverThere is a silver fund paying up to 20% in yearly distributions - no mining stocks, no options required. The s...Investors Alley | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredDid you miss The Dark AI Summit?Over 55,000 people attended Jeff Brown's Dark AI Summit, where he revealed a private AI company he believes ho...Brownstone Research | SponsoredWhy Elon just bought a power plant (Ticker inside)Elon Musk is burning nearly $1 billion a month because he cannot power the world's largest supercomputer witho...Behind the Markets | SponsoredIran War Update: Trump’s Hand-Written Letter Reveals What Comes NextJim Rickards has uncovered what he believes is Trump's economic plan, with a key trigger date of May 15. The F...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Weight Loss Drug & Treatment ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Weight Loss Drug & Treatment ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free THNR Stock Alerts